In late 2011, before the presidential election, the Yu Chang (later TaiMed) Biotech case broke out, involving then-presidential candidate Tsai Ing-wen. As the Vice Premier, Tsai had signed off on a government investment in Yu Chang and later became the chairperson of the company after leaving office. This case exposed a serious "revolving door" and conflict of interest controversy, raising doubts about the ethics of top green camp officials in utilizing national resources to benefit their private enterprises.
‹ 返回事件列表已結案
The Yu Chang Biotech Scandal: Tsai Ing-wen Involved in Conflict of Interest Controversy Before the General Election
✦ Support Independent Media
Your coffee keeps the truth alive
We accept no corporate or political funding. Your direct support is the only way we can keep uncovering buried facts. Every contribution powers independent journalism.
Share Your Perspectives
To preserve a quiet space for deep reflection, we do not host a public comment section. If you have insights on this article, click below to share it to your own social space and start a meaningful conversation with your network.